オートインジェクターの世界市場 2023-2027

当レポートでは、オートインジェクターの市場規模は、2022年から2027年の間に1,340億1,458万米ドルの増加が見込まれ、予測期間中に25.14%のCAGRで成長すると予測しています。

当レポートでは、オートインジェクター市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新の動向と促進要因、市場全体の環境に関する最新の分析を提供しています。市場は、アレルギーの有病率の増加と即時治療の必要性、注射療法の人気の高まり、新製品の商業認可の増加によって牽引されています。

本調査では、今後数年間のオートインジェクター市場の成長を促進する主な理由の一つとして、企業間の戦略的提携を挙げています。また、新製品発売の増加や革新的なアナフィラキシーオートインジェクターの認知度向上は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場別分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• オートインジェクターの世界市場 2017-2021
• 用途別分析 2017-2021
• エンドユーザーセグメント分析 2017-2021
• 地域別分析 2017-2021
• 国別分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• アナフィラキシー：市場規模と予測 2022-2027
• 多発性硬化症：市場規模と予測 2022-2027
• 関節リウマチ：市場規模と予測 2022-2027
• 糖尿病：市場規模と予測 2022-2027
• 市場機会：用途別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 病院と診療所：市場規模と予測 2022-2027
• 自己管理：市場規模と予測 2022-2027
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Amgen Inc.
• Bayer AG
• Becton Dickinson and Co.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Halozyme Therapeutics Inc.
• Merck KGaA
• Owen Mumford Ltd.
• Pfizer Inc.
• Recipharm AB
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Ypsomed AG

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global autoinjectors market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Application - Market share 2022-2027 (%)
• Exhibits31: Data Table on Application - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Anaphylaxis - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Anaphylaxis - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Diabetes - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Diabetes - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Diabetes - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Diabetes - Year-over-year growth 2022-2027 (%)
• Exhibits50: Market opportunity by Application ($ million)
• Exhibits51: Data Table on Market opportunity by Application ($ million)
• Exhibits52: Chart on End-user - Market share 2022-2027 (%)
• Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits54: Chart on Comparison by End-user
• Exhibits55: Data Table on Comparison by End-user
• Exhibits56: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Self-administration - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Self-administration - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Self-administration - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Self-administration - Year-over-year growth 2022-2027 (%)
• Exhibits64: Market opportunity by End-user ($ million)
• Exhibits65: Data Table on Market opportunity by End-user ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits107: Market opportunity By Geographical Landscape ($ million)
• Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits109: Impact of drivers and challenges in 2022 and 2027
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: AbbVie Inc. - Overview
• Exhibits116: AbbVie Inc. - Product / Service
• Exhibits117: AbbVie Inc. - Key news
• Exhibits118: AbbVie Inc. - Key offerings
• Exhibits119: Amgen Inc. - Overview
• Exhibits120: Amgen Inc. - Product / Service
• Exhibits121: Amgen Inc. - Key offerings
• Exhibits122: Bayer AG - Overview
• Exhibits123: Bayer AG - Business segments
• Exhibits124: Bayer AG - Key news
• Exhibits125: Bayer AG - Key offerings
• Exhibits126: Bayer AG - Segment focus
• Exhibits127: Becton Dickinson and Co. - Overview
• Exhibits128: Becton Dickinson and Co. - Business segments
• Exhibits129: Becton Dickinson and Co. - Key news
• Exhibits130: Becton Dickinson and Co. - Key offerings
• Exhibits131: Becton Dickinson and Co. - Segment focus
• Exhibits132: Eli Lilly and Co. - Overview
• Exhibits133: Eli Lilly and Co. - Product / Service
• Exhibits134: Eli Lilly and Co. - Key offerings
• Exhibits135: F. Hoffmann La Roche Ltd. - Overview
• Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits137: F. Hoffmann La Roche Ltd. - Key news
• Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits140: GlaxoSmithKline Plc - Overview
• Exhibits141: GlaxoSmithKline Plc - Business segments
• Exhibits142: GlaxoSmithKline Plc - Key news
• Exhibits143: GlaxoSmithKline Plc - Key offerings
• Exhibits144: GlaxoSmithKline Plc - Segment focus
• Exhibits145: Halozyme Therapeutics Inc. - Overview
• Exhibits146: Halozyme Therapeutics Inc. - Product / Service
• Exhibits147: Halozyme Therapeutics Inc. - Key offerings
• Exhibits148: Merck KGaA - Overview
• Exhibits149: Merck KGaA - Business segments
• Exhibits150: Merck KGaA - Key news
• Exhibits151: Merck KGaA - Key offerings
• Exhibits152: Merck KGaA - Segment focus
• Exhibits153: Owen Mumford Ltd. - Overview
• Exhibits154: Owen Mumford Ltd. - Product / Service
• Exhibits155: Owen Mumford Ltd. - Key offerings
• Exhibits156: Pfizer Inc. - Overview
• Exhibits157: Pfizer Inc. - Product / Service
• Exhibits158: Pfizer Inc. - Key news
• Exhibits159: Pfizer Inc. - Key offerings
• Exhibits160: Recipharm AB - Overview
• Exhibits161: Recipharm AB - Business segments
• Exhibits162: Recipharm AB - Key offerings
• Exhibits163: Recipharm AB - Segment focus
• Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits169: Viatris Inc. - Overview
• Exhibits170: Viatris Inc. - Business segments
• Exhibits171: Viatris Inc. - Key offerings
• Exhibits172: Viatris Inc. - Segment focus
• Exhibits173: Ypsomed AG - Overview
• Exhibits174: Ypsomed AG - Business segments
• Exhibits175: Ypsomed AG - Key offerings
• Exhibits176: Ypsomed AG - Segment focus
• Exhibits177: Inclusions checklist
• Exhibits178: Exclusions checklist
• Exhibits179: Currency conversion rates for US$
• Exhibits180: Research methodology
• Exhibits181: Validation techniques employed for market sizing
• Exhibits182: Information sources
• Exhibits183: List of abbreviations

Technavio has been monitoring the autoinjectors market and is forecast to grow by $134014.58 mn during 2022-2027, accelerating at a CAGR of 25.14% during the forecast period. Our report on the autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies and the need for immediate care, the growing popularity of injectable therapies, and the rise in commercial approvals of new products.

Technavio's autoinjectors market is segmented as below:

By Application

• Anaphylaxis
• Multiple sclerosis
• Rheumatoid arthritis
• Diabetes

By End-user

• Hospitals and clinics
• Self-administration

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strategic alliances between companies as one of the prime reasons driving the autoinjectors market growth during the next few years. Also, increase in new product launches and rise in awareness of innovative anaphylaxis autoinjectors will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the autoinjectors market covers the following areas:

• Autoinjectors market sizing
• Autoinjectors market forecast
• Autoinjectors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoinjectors market vendors that include AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Halozyme Therapeutics Inc., Johnson and Johnson Services Inc., Johnson Medtech LLC, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., RAVIMED Sp. zoo, Recipharm AB, SHL Medical AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed AG. Also, the autoinjectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global autoinjectors market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global autoinjectors market 2017 - 2021 ($ million)
• 4.2 Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Anaphylaxis - Market size and forecast 2022-2027
• Exhibit 34: Chart on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Anaphylaxis - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Anaphylaxis - Year-over-year growth 2022-2027 (%)
• 6.4 Multiple sclerosis - Market size and forecast 2022-2027
• Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• 6.5 Rheumatoid arthritis - Market size and forecast 2022-2027
• Exhibit 42: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• 6.6 Diabetes - Market size and forecast 2022-2027
• Exhibit 46: Chart on Diabetes - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Diabetes - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Diabetes - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Diabetes - Year-over-year growth 2022-2027 (%)
• 6.7 Market opportunity by Application
• Exhibit 50: Market opportunity by Application ($ million)
• Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
• 7.2 Comparison by End-user
• Exhibit 54: Chart on Comparison by End-user
• Exhibit 55: Data Table on Comparison by End-user
• 7.3 Hospitals and clinics - Market size and forecast 2022-2027
• Exhibit 56: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
• 7.4 Self-administration - Market size and forecast 2022-2027
• Exhibit 60: Chart on Self-administration - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Self-administration - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Self-administration - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Self-administration - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by End-user
• Exhibit 64: Market opportunity by End-user ($ million)
• Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ million)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 115: AbbVie Inc. - Overview
• Exhibit 116: AbbVie Inc. - Product / Service
• Exhibit 117: AbbVie Inc. - Key news
• Exhibit 118: AbbVie Inc. - Key offerings
• 12.4 Amgen Inc.
• Exhibit 119: Amgen Inc. - Overview
• Exhibit 120: Amgen Inc. - Product / Service
• Exhibit 121: Amgen Inc. - Key offerings
• 12.5 Bayer AG
• Exhibit 122: Bayer AG - Overview
• Exhibit 123: Bayer AG - Business segments
• Exhibit 124: Bayer AG - Key news
• Exhibit 125: Bayer AG - Key offerings
• Exhibit 126: Bayer AG - Segment focus
• 12.6 Becton Dickinson and Co.
• Exhibit 127: Becton Dickinson and Co. - Overview
• Exhibit 128: Becton Dickinson and Co. - Business segments
• Exhibit 129: Becton Dickinson and Co. - Key news
• Exhibit 130: Becton Dickinson and Co. - Key offerings
• Exhibit 131: Becton Dickinson and Co. - Segment focus
• 12.7 Eli Lilly and Co.
• Exhibit 132: Eli Lilly and Co. - Overview
• Exhibit 133: Eli Lilly and Co. - Product / Service
• Exhibit 134: Eli Lilly and Co. - Key offerings
• 12.8 F. Hoffmann La Roche Ltd.
• Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 GlaxoSmithKline Plc
• Exhibit 140: GlaxoSmithKline Plc - Overview
• Exhibit 141: GlaxoSmithKline Plc - Business segments
• Exhibit 142: GlaxoSmithKline Plc - Key news
• Exhibit 143: GlaxoSmithKline Plc - Key offerings
• Exhibit 144: GlaxoSmithKline Plc - Segment focus
• 12.10 Halozyme Therapeutics Inc.
• Exhibit 145: Halozyme Therapeutics Inc. - Overview
• Exhibit 146: Halozyme Therapeutics Inc. - Product / Service
• Exhibit 147: Halozyme Therapeutics Inc. - Key offerings
• 12.11 Merck KGaA
• Exhibit 148: Merck KGaA - Overview
• Exhibit 149: Merck KGaA - Business segments
• Exhibit 150: Merck KGaA - Key news
• Exhibit 151: Merck KGaA - Key offerings
• Exhibit 152: Merck KGaA - Segment focus
• 12.12 Owen Mumford Ltd.
• Exhibit 153: Owen Mumford Ltd. - Overview
• Exhibit 154: Owen Mumford Ltd. - Product / Service
• Exhibit 155: Owen Mumford Ltd. - Key offerings
• 12.13 Pfizer Inc.
• Exhibit 156: Pfizer Inc. - Overview
• Exhibit 157: Pfizer Inc. - Product / Service
• Exhibit 158: Pfizer Inc. - Key news
• Exhibit 159: Pfizer Inc. - Key offerings
• 12.14 Recipharm AB
• Exhibit 160: Recipharm AB - Overview
• Exhibit 161: Recipharm AB - Business segments
• Exhibit 162: Recipharm AB - Key offerings
• Exhibit 163: Recipharm AB - Segment focus
• 12.15 Teva Pharmaceutical Industries Ltd.
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.16 Viatris Inc.
• Exhibit 169: Viatris Inc. - Overview
• Exhibit 170: Viatris Inc. - Business segments
• Exhibit 171: Viatris Inc. - Key offerings
• Exhibit 172: Viatris Inc. - Segment focus
• 12.17 Ypsomed AG
• Exhibit 173: Ypsomed AG - Overview
• Exhibit 174: Ypsomed AG - Business segments
• Exhibit 175: Ypsomed AG - Key offerings
• Exhibit 176: Ypsomed AG - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 179: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources
• 13.5 List of abbreviations
• Exhibit 183: List of abbreviations